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Apolipoprotein E Genotypes and Behavioural and Psychological Symptoms of 
Dementia (BPSD) in Malaysian Patients with Dementia
(Genotip Apolipoprotein E dan Gejala Tingkah Laku dan Psikologi Demensia (BPSD) 
dalam Kalangan Pesakit Demensia di Malaysia)
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SuRiATi MohAMED SAini, ABDuL hAMiD ABDuL RAhMAn & ShAMSuL AzhAR ShAh
ABSTRACT
The aim of this study was to determine the relationships between ApoE genotypes and ‘behavioural and psychological 
symptoms of dementia’ (BPSD). A cross-sectional study was conducted on 46 outpatients with dementia (aged 60 and 
above) and their caregivers attending the psychogeriatric clinics at Universiti Kebangsaan Malaysia Medical Centre 
(UKMMC) and Hospital Kuala Lumpur. Neuropsychiatric Inventory (NPI) was used for the assessment of BPSD. The patients’ 
blood samples were taken for Apolipoprotein genotyping after consented by the caregivers. There were more female 
(69.6%) and Chinese (50%) patients with a mean age of 73.7 years. ApoE ε3/ε3 was the most common ApoE allele 
(60.7%) and mostly found in Chinese patients. ApoE genotype was significantly associated with ethnicity (p=0.03) and 
marital status (p=0.01). Alzheimer disease was the most common subtype of dementia (41.3%) and the highest carrier 
of ApoE ε3/ε3 (30.4%). The ApoE ε4/ ε4 scored highest in BPSD median score 44 (17.5 to 90) but the relationships 
between ApoE genotypes and subtypes of dementia or BPSD scores were not significant (p=0.20; p=0.64). Agitation 
was the most common symptom, with delusions showing the highest scores on the NPI with no significant association 
to ApoE 4 allele. In conclusion, there was no significant relationship between ApoE genotypes and severity or types of 
BPSD in dementia patients. 
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ABSTRAK
Tujuan kajian ini adalah untuk menentukan kaitan antara jenis gen Apolipoprotein (Apo) E dan gejala tingkah laku 
dan psikologi demensia (BPSD). Satu kajian menggunakan kaedah hirisan lintang telah dikendalikan dalam kalangan 
sekumpulan 46 pesakit luar yang berumur 60 tahun ke atas bersama dengan penjaga masing-masing di klinik psikogeriatrik 
di Pusat Perubatan Universiti Kebangsaan Malaysia (PPUKM) dan Hospital Kuala Lumpur. ‘BPSD’ pesakit telah 
dinilai dengan menggunakan inventori neuropsikiatri (NPI). Sampel darah pesakit diambil untuk menentukan genotip 
Apolipoprotein E setelah kebenaran diberi oleh penjaga pesakit. Terdapat lebih ramai pesakit perempuan (69.6%) dan 
berketurunan Cina (50%) dengan min umur 73.7 tahun. ApoE ε3/ε3 merupakan alel ApoE yang terbanyak (60.7%) dan 
banyak terdapat dalam kalangan pesakit berketurunan Cina. Genotip ApoE berkait rapat secara signifikan dengan bangsa 
(p=0.03) dan status perkahwinan (p=0.01). Penyakit Alzheimer merupakan jenis demensia yang terbanyak (41.3%) dan 
pembawa ApoE ε3/ε3 (30.4%) yang tertinggi. ApoE ε4/ ε4 menunjukkan skor median BPSD yang tertinggi iaitu 44 (17.5-
90) tetapi tiada kaitan rapat secara signifikan antara genotip ApoE dan jenis-jenis demensia atau skor BPSD (p=0.20; 
p=0.64). Agitasi merupakan gejala yang paling kerap berlaku dan delusi menunjukkan skor NPI yang tertinggi, tetapi 
keduanya tiada kaitan rapat yang signifikan dengan alel ApoE. Kesimpulannya, tiada hubungan yang signifikan antara 
genotip ApoE dengan keterukan atau jenis BPSD dalam kalangan pesakit demensia di Malaysia.
Kata kunci: Apolipoprotein E; demensia
inTRoDuCTion
Apolipoprotein E (ApoE) was initially known to be 
involved in the transport of cholesterol and development 
of cardiovascular disease but more recently, its role has 
extended to other biological processes not directly related 
to lipoprotein transport, including,  immunoregulation, 
nerve regeneration, tissue repair, cognitive functioning 
and Alzheimer disease (AD). ApoE is now identified as 
a non-modifiable factor of dementia and the only valid 
determinant of AD of the sporadic type (Seripa et al. 
2009). 
 ApoE exists in people in three different forms or 
alleles (ApoE 2,3,4) which differ from each other by one 
to two base pairs. Each person has two copies of the ApoE 
gene. Thus an individual could have any of the following 
combinations: ApoE 2/2, 3/3, 4/4, 2/3, 3/4 and 2/4. The 
ApoE locus on chromosome 19 is a gene that contributes 
to the susceptibility of a person for AD. The progression of 
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illness and age of onset of AD is influenced by the ApoE 
polymorphism, defined by these three alleles of the gene: 
ε2 (normal); ε3 and ε4 (dysfunctional).
 The risks of getting Alzheimer disease increases by 
a factor of 4 if an individual has one copy of the ApoE ε4 
gene and a factor of 10 if having two copies of the ApoE 
ε4 gene (Bales et al. 2002), more likely for the late-onset 
AD (Wijsman et al. 2011). however, there is also evidence 
that the ApoE2 allele may serve as a protective role in AD 
(Corder et al. 1994). The genotype most at risk for AD at 
earlier age is the homozygous ApoE 4/4, at higher risk 
than the ApoE 3/4 genotype. The genotypes ApoE 3/3 is 
considered to be at normal risk for AD and ApoE 2/3 at a 
lesser risk for the disease. interestingly, people with both 
a copy of the 2 allele and the 4 allele, ApoE 2/4, are at 
normal risk similar to the ApoE 3/3 genotype. Slooter et al. 
(1997) reported that the ApoE ε4 allele has been known to 
be a genetic risk factor for dementia with stroke, including 
vascular dementia (VaD), AD with cardiovascular diseases 
(CVD) and other dementias, like dementia of Lewy Body 
(DLB).
 The distribution of ApoE alleles vary in different 
ethnic groups throughout the world (Corbo & Scacchi 
1999). it was noted that the most common in all human 
societies is the ApoE allele 3, especially in populations 
with long-established agricultural economy (Takeda et 
al. 2010). Frequencies of the ApoE4 allele are reported 
to be relatively increased in healthy Africans and some 
non-Africans, including indigenous people in Malaysia 
by about 14–41% (Kalaria et al. 2008). A study by Wan 
et al. (2004) which had determined ApoE genotyping in 
Malaysia, found that the most common ApoE genotype 
among the Malays, Chinese and indians was E3/E3, thus 
making E3/E3 as the most common ApoE allele among 
Malaysians. This study also reported that the ApoE ε2 
allele was totally absent among the indians.
 Behavioural and psychological symptoms of 
dementia (BPSD) are non-cognitive symptoms commonly 
experienced by dementia patients. The most common are 
depressive symptoms followed by anxiety and paranoid or 
schizophreniform psychosis. it is important to recognize 
the coexistence of BPSD as they are responsible for the 
increased number of hospitalizations or emergency room 
visits, premature institutionalizations, increased burden of 
care, disability in patients with dementia and diminished 
quality of life for patients and caregivers. A Brazilian study 
on BPSD reported that almost 80% of patients with AD had 
one or more symptoms whereby apathy was present in 
more than half (53%), followed by depression (38%), sleep 
alterations (38%) and anxiety (25%) (Tatsch et al. 2006). 
 There have been equivocal opinions as whether 
ApoE causes BPSD (Pritchard et al. 2007). Studies have 
shown that ApoE 4 carriers are significantly more likely 
to demonstrate agitation and aggression in AD (Craig 
et al. 2004) and have a 19.0-fold risk of developing 
hallucinations and 3.4 – fold risk for delusions (Chang et 
al. 2004). A study in Taiwan by Chen et al. (2011) found 
that ApoE ε 4 had higher risk for subsyndromal agitation 
/aggression and delusion in AD. unfortunately, there is a 
lack of local data on the ApoE genotyping in dementia. 
This study aimed to identify ApoE genotypes of patients 
with dementia and investigate for their associations with 
disturbing behavioural and psychiatric symptoms.
MATERiALS AnD METhoDS
This cross-sectional study was conducted in the outpatient 
psychogeriatric clinics of uKM Medical Centre (uKMMC) 
and hospital Kuala Lumpur (hKL) from March to June 
2011. uKMMC is a university hospital serving the population 
of the southern part of Kuala Lumpur, particularly, the area 
of Cheras and receives referrals from most hospitals and 
private clinics in the Klang Valley. hospital Kuala Lumpur 
is Malaysia’s premier and biggest Government- funded 
hospital, serving as a major tertiary-level hospital for 
referrals nationwide. uKM Medical Molecular Biology 
institute (uMBi) was formed in July 2003 and is recognised 
as a higher institution Centre of Excellence (hiCoE) by 
the Ministry of higher Education in molecular science 
research. ApoE genotyping on blood samples taken from 
patients was done here.
 The study subjects comprised of a dyad group of elderly 
outpatients aged 60 years and above, diagnosed as having 
dementia and their caregivers. All patients involved in this 
study had been diagnosed as Dementia according to DSM-
1V TR by the psychogeriatricians. They comprised of newly 
referred patients as well as those already on follow-up visits 
at the clinics. Dementia was classified into Alzheimer’s 
type, Vascular type and others for statistical analysis. 
Exclusion criteria included patients with major psychiatric 
diagnoses other than dementia, those under institutional care 
(nursing home or old folks’ home), those who were cared 
for by hired sitters or housemaids at home or those whose 
caregivers refused to allow consent for this study. 
 The patients and their caregivers were explained 
about the study before consent was taken from the latter. 
Confidentiality was assured by identifying subjects through 
a registration numbering system instead of using patients’ 
names. After undergoing psychological assessments, the 
patients’ blood were taken and sent for ApoE genotyping 
on the same day. 
 information on sociodemographic data and clinical 
information were gathered using a questionnaire to be 
filled by the caregiver. The information was later confirmed 
through patients’ medical notes if caregivers were unable 
to verify any information. BPSD was assessed using the 
neuropsychiatric inventory questionnaire (nPi) (Cummings 
et al. 1994). 
 The nPi is a relatively brief interview (10-15 min) 
assessing non-cognitive symptoms of dementia. it has 
10 behavioural disturbance domains covering delusion, 
hallucination, dysphoria/depression, anxiety, agitation/
aggression, euphoria, disinhibition, irritability/lability, 
apathy and aberrant motor behaviour. night time behaviour 
and eating changes had been later included in the list. 
Specific follow-up questions were used to confirm the 
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presence of symptoms. Caregiver was asked to score the 
frequency of these symptoms as: 1 (occasionally), 2 (often), 
3 (frequently) and 4 (very frequently). Each domain would 
be scored between 0-12 with a total score of all domains 
of 0 to 144. Caregiver was asked to score their distress 
level whether; not all, minimal, mild, moderate, severe 
and very severe. Permission to use this questionnaire had 
been granted by the author, Jeffry L. Cummings. This 
research project had been approved by the uKMMC Ethical 
Committee and the Ministry of health national Medical 
Research Register.
RESuLTS
A total of 74 dementia patients were offered to participate 
in the study from hKL and uKKMC Psychogeriatric clinics. 
however, 28 subjects had to be excluded from the study 
due to patients being too agitated and uncooperative for 
assessment of blood-taking, clotted blood specimens, 
language difficulties, coming from nursing homes or were 
being cared for by their housemaids. So, only 46 blood 
samples were able to be genotyped for ApoE alleles within 
the stipulated research period. 
APoE GEnoTyPES AnD SoCio DEMoGRAPhiC AnD 
CLiniCAL ChARACTERiSTiCS oF ThE PATiEnTS
Relationships between ApoE and all sociodemographic 
data are illustrated in Table 1. The most common ApoE 
genotype was ApoE ε3/ε3 (60.7%), followed by ApoE ε3/
ε4 (13%), ApoE ε2/ε3 (10.8%), ApoE ε4/ε4 (8.7%) and 
ApoE ε2/ε4 (6.25%). There were no patients with ApoE 
ε2/ε2. ApoE ε3/ε3 was the most frequent genotype among 
all the three major races, more so among the Chinese and 
this distribution showed significant statistical difference 
(p=0.03). ApoE ε3/ε3 was also statistically more significant 
among the married subjects than those without spouse 
(0.01). however, ApoE genotyping did not show any 
significant statistical difference in its association with other 
sociodemographic data such as age, gender, education 
achievement and employment. 
 Similarly, ApoE was not significantly related to the 
types of dementia, age of onset of dementia or family 
history of dementia. Similar negative finding was also 
found in the poor relationship between ApoE genotype 
and medical comorbidities such as diabetes mellitus, 
hypertension or heart disease.
APoE GEnoTyPE AnD BPSD
The most common BPSD was agitation (73.9%), followed 
by apathy (67.4%), delusions (67%), irritability (67%) 
and sleeping problems (65.2%) (Figure 1). however, 
delusions rated the highest BPSD total score (115) 
followed by hallucinations (104) and apathy (92) (Table 
2). x2 Kruskal Wallis test showed that among the ApoE 
genotypes, ApoE ε4/ ε4 scored the highest with a BPSD 
median score of 44 (17.5 to 90) (Table 3). however, the 
relationship between ApoE genotypes and BPSD score 
was not significant (p=0.64).
TABLE 1. Relationship between ApoE genotype and socio demographic data
ApoE genotype ε2/ε3n=5
ε3/ ε3
n=28
ε2 /ε4
n=3
ε3/ ε4
n=6
ε4 /ε4
n=4 test p
Age
 60-69 (n=10)
 70-79 (n=21)
 ≥80 (n=5)
3(6.5)
1(2.2)
1(2.2)
8(17.4)
13(28.3)
 7(15.2)
1 (2.2)
 1 (2.2)
 1 (2.2)
1(2.2)
5(10.9)
0
0
4(8.7)
 0
x2 0.25
Gender
 Female (n=32)
 Male (n=14)
1(2.2)
4(8.7)
10(21.7)
 18 (39.1) 
0
3(6.5)
2(4.3)
4(8.7)
1(2.2)
3(6.5)
x2 0.73
Race
 Malay (n=14)
 Chinese(n=23)
 indian (n=8)
 others (n=1)
0
4(8.7)
1(2.2)
0
11(23.9)
12(26.1)
5(10.9)
0
1(2.2)
 2(4.3)
0
0
1(2.2)
 5(10.9)
0
0
1(2.2)
 0
2(4.3)
1(2.2)
x2 0.03
Employment
 never had(n=13)
 Ever had (n=33)
2(4.3)
3(6.5)
6(13)
22(47.8)
1(2.2)
2(4.3)
2(4.3)
4(8.7)
2(4.3)
2(4.3)
x2 0.73
Marital status
 Married (n=29)
 no spouse(n=17)
4(8.7)
1(2.2)
18(39.1)
10(21.7)
0
3(6.5)
6(13)
 0
1(2.2)
3(6.5)
x2 0.01
Education
 Low(n=33)
 high(n=13)
5(10.9)
0
19(14.3)
 9(19.6) 
3(6.5)
 0
5(10.9)
1(2.2)
1(2.2)
3(6.5)
x2 0.89
 
x2 Pearson chi square
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FiGuRE 1. Frequency distribution of BPSD domains
TABLE 2. Total scores of BPSD symptoms 
BPSD symptoms Total score 
hallucination
Delusion
Agitation
Depression
Anxiety
irritability
Euphoria
Apathy
Disinhibition
Motor behaviour
Sleeping problem
Eating problem
104
115
78
53
51
88
26
92
50
51
84
45
TABLE 3. Relationship between ApoE genotype 
and BPSD score
APoE 
genotype
BPSD SCoRE x2 df p
ε2/ε3
n=5 29(iQR: 14 - 31) 
ε3/ ε3
n=28 19 (iQR:7.5 - 38.5) 1.67 3 0.64
ε2 /ε4
n=3 35 (iQR:28 - 45.5)
ε3/ ε4
n=6 12.5(iQR: 6 - 47)
ε4 /ε4
n=4 44 (17.5 - 90)
x2 Kruskal wallis test
 Statistical analysis using chi square test showed 
that most BPSD symptoms were more predominantly 
presented in the ApoE genotype ε3/ε3 such as eating 
disorder (52.2%), delusions (43.5%) and agitation 
(41.3%) (Table 4). however, none of the ApoE genotypes 
showed any significant association with the different 
types of BPSD. only 28.3% of the patients had ApoE 4 
alleles. Similarly, there were no significant associations 
between ApoE 4 and subtypes of dementia (p=0.51), 
between ApoE 4 and agitation (the most common BPSD) 
(p=0.73) or between ApoE 4 and psychosis (delusions 
and hallucinations) (p=0.33).
DiSCuSSion
in this study, of 46 patients with dementia, the most 
common ApoE allele was ApoE ε3/ ε3. Such finding was 
also reported by Wan et al. (2004) in a local population 
study and by Tan et al. (2003) in a study on Singapore 
population. Both studies also reported relatively lower 
incidence of ApoE ε4 than other genotypes. This study 
revealed significant relationship between ApoE genotype 
and ethnicity, similar to that of a study cited by Kalaria et 
al. (2008). in this study, Chinese patients constituted 50% 
of the subjects and this reflected the racial distribution 
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of Kuala Lumpur (DBKL 2012). Another reason for the 
ethnic differences could be due to the different subjective 
experience of burden of care among the different races, 
as reported in other local studies on dementia (Choo 
et al. 2003; Rosdinom et al. 2011a) and on Parkinson 
disease caregivers (Rosdinom et al. 2011b). The Chinese 
caregivers experienced higher level of burden compared 
with the indians and Malays, thus tend to bring their 
relatives with dementia for treatment more readily than 
others. Cultural misperception towards dementia as part 
of normal ageing among the Malays might also be another 
contributing factor as to the lower percentage in Malay 
patients seeking treatment in hospitals.
 There were no significant relationships between 
ApoE genotypes and the patients’ clinical characteristics 
(duration of having dementia, family history of dementia 
and medical comorbidities) or the age of onset of the BPSD 
symptoms. on the contrary, a study by Romas et al. (2002) 
among Caribbean Hispanics showed that ApoE ε4 allele 
carriers had increased risk of developing early onset AD. 
 In this study, ApoE ε3/ε3 was the most prevalent of 
the ApoE genotypes and patients with ApoE ε3/ε3 had 
significantly higher BPSD score and experienced a wider 
range of BPSD symptoms than other ApoE alleles. Patients 
with ApoE4 allele, despite their smaller number, exhibited 
more hallucinations, agitation, delusion and apathy. The 
TABLE 4. Relationship between ApoE genotype and BPSD
BPSD
ε2/ε3
n=5
ε3/ ε3
n=28
ε2 /ε4
n=3
ε3/ ε4
n=6
ε4 /ε4
n=4 test p
hallucination
 no (n=21)
 yes (n=25)
3(6.5)
2(4.3)
12 (26.1)
16(34.8)
1(2.2)
2 (4.3)
3(6.5)
3(6.5)
2(4.3)
2(4.3)
x2 0.943
Delusion
 no (n=17)
 yes (n=29)
3(6.5)
2(4.3)
8(17.4)
20(43.5)
1(2.2)
2(4.3)
3(6.5)
3(6.5)
2(4.3)
2(4.3)
x2 0.604
Anxiety
 no (n=18)
 yes (n=28)
2(4.3)
3(6.5)
11(23.9)
 17(37)
0
3(6.5)
4(8.7)
2(4.3)
1(2.2)
3(6.5)
x2 0.383
Depression
 no (n=22)
 yes (n=28)
2(4.3)
3(6.5)
14(30.4)
14(30.4)
1(2.2)
2(4.3)
4(8.7)
 2(4.3)
1(2.2)
 3(6.5)
x2 0.714
Apathy
 no (n=19)
 yes (n=27)
3(6.5)
2(4.3)
13(28.3)
15(32.6)
0
3(6.5)
2(4.3)
4(8.7)
1(2.2)
 3(6.5)
x2 0.444
Euphoria
 no (n=23)
 yes (n=23)
1(2.2)
 4(8.7)
13(28.3)
 15(32.6)
2(4.3) 
1(2.2)
5(10.9)
 1(2.2)
2(4.3)
 2(4.3)
x2 0.293
Agitation
 no (n=15)
 yes (n=31)
1(2.2)
 4(8.7)
9(19.6)
 16(41.3)
1(2.2)
 2(4.3)
4(8.7)
 2(4.3)
6(13)
 4(8.7)
x2 0.243
irritability
 no (n=23)
 yes (n= 23)
3(6.5)
 2(4.3)
16(34.8)
 12(26.1)
1(2.2)
 2(4.3)
3(6.5)
 3(6.5)
0
 4 (8.7)
x2 0.277
Disinhibition
 no (n=13)
 yes (n=23)
3(6.5)
 2(4.3)
11(23.9)
17(37)
1(2.2)
 2(4.3)
3(6.5)
3(6.5)
1(2.2)
 3(6.5)
x2 0.832
Motor behaviour
 no (n=20)
 yes (n=26)
3(6.5)
2(4.3)
12(26.1)
16(34.8)
1(2.2)
2(4.3)
4(8.7)
 2(4.3)
0
4(8.7)
x2 0.280
Sleeping 
 no (n=18)
 yes (n=28)
3(6.5)
2(4.3)
11(23.9)
17(37 )
0
3(6.5)
3(6.5)
 3(6.5)
1(2.2)
 3(6.5)
x2 0.482
Eating 
 no (n=8)
 yes (n=38)
0
 5(10.9)
4(8.7)
24(52.2)
0
3(6.5)
2(4.3)
 4(8.7)
2(4.3)
 2(4.3)
x2 0.207
x2 Pearson chi square test
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high percentage of agitation in ApoE 4 allele was also 
reported in a study by Craig et al. (2004) which showed 
that those with ApoE ε4 genes were significantly more 
likely to demonstrate agitation.
 Depression was more likely to occur in patients with 
ApoE ε3, similar to findings of a study reported by Liu 
et al. (2002) which did not find any association between 
depression and the presence or absence of the epsilon4 
or epsilon2 allele. however, other studies have shown 
that depressive symptomatology in AD might be related 
to low serum cholesterol in ApoE ε2 carriers (Holmes 
et al. 1996) and less likely in AD with ApoE ε4 (Ballard 
et al. 1997). hallucinations and delusions were higher 
in ApoE ε3/ε3 genotype, which differed from findings 
by zdanys et al. (2007) in which psychotic symptoms 
were associated with ApoE ε4 in the AD patients. Another 
interesting finding in this study was that there were more 
sleeping and eating disorders occurring in patients with 
the ApoE ε3/ε3 genotype, even though their relationships 
were not significant. 
 There were several limitations of this study which 
could have influenced the outcome of study. The small 
number of subjects could have affected the power of this 
study. Most of the study variables were not normally 
distributed and all the results not conclusive even though 
some of them had significant relationships and had similar 
outcomes as previous studies. one option was to recruit 
study subjects from other hospitals and community-based 
populations so that it would be more representative of the 
true population of Malaysia. A bigger sample size would 
allow classification into the different types of dementia 
and comparison with different types of BPSD. 
 Blood-taking procedure has always been unpopular 
and many caregivers refused to be involved as it made 
patients agitated during the procedure. This further reduced 
the number of potential suitable study subjects.
 in this study, the nPi (Malay version) had not 
been validated in the local population. BPSD severity 
was assessed using the nPi, which involved subjective 
assessment by the caregivers. Distressed caregivers tend 
to score higher for the BPSD severity compared with non-
distressed caregivers. There was possibility of under-
reporting by the caregivers of certain symptoms due to 
cultural reasons or lack of awareness of these symptoms 
as part of the illness. in the other questionnaires, 
treatment history was not included in this study. This is 
a relevant issue as BPSD symptoms; frequency, severity 
and its total score might be influenced by treatment 
used, for example, anti- psychotics, benzodiazepines, 
antidepressant or hypnotics.
 The role of ApoE as a biomarker in the early 
intervention of dementia against development of BPSD is 
still not proven. other biomarkers such as neuroimaging 
findings when used together with ApoE may be more 
reliable in the study on BPSD. A comparative study between 
ApoE ε4 groups and non ApoE ε4 or case control study 
would have been a better choice. 
ConCLuSion
in this study, dementia was more prevalent among the 
Chinese patients with females experiencing more severe 
BPSD. other socio demographic variables did not show any 
significant associations with BPSD. Depression, sleeping 
disorder and disinhibition were significantly presented in 
Dementia of Alzheimer type even though the BPSD median 
scores were higher in other types of dementia. Agitation 
was the most common symptom, with delusions showing 
the highest scores on the nPi.
 ApoE genotype was significantly associated with 
ethnicity and marital status. The most common genotype 
was ApoE ε3/ε3, more so among the Chinese patients. 
Alzheimer disease was the most common subtype of 
dementia and the highest carrier of ApoE ε3/ε3. 
 The ApoE allele 4 occurred more frequently in Dementia 
of Alzheimer type with ApoE ε4/ ε4 scoring the highest 
BPSD median score 44 (17.5 to 90). however, there were 
no associations between ApoE genotypes and subtypes of 
dementia or BPSD scores. neither was there any association 
between ApoE 4 allele and agitation or psychosis.
 Despite of the lack of significant associations between 
ApoE genotypes and types or severity of BPSD among 
our population, it is hoped that some of the findings from 
this study may offer insight into our patients’ genetic 
predisposition to dementia and BPSD.
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